General
Baricitinib improves patient-reported outcomes in RA
 

Baricitinib improves patient-reported outcomes in RA

Shared by:

 
Baricitinib may produce meaningful improvements in patient-reported outcomes in rheumatoid arthritis (RA) patients with previously inadequate responses to biological disease-modifying antirheumatic drugs, according to data from the RA-BEACON trial.
 
specialty.mims.com
 
12 Dec 2016 - General